Xu, L.;                     Shao, F.;                     Luo, T.;                     Li, Q.;                     Tan, D.;                     Tan, Y.    
        Pan-Cancer Analysis Identifies CHD5 as a Potential Biomarker for Glioma. Int. J. Mol. Sci. 2022, 23, 8489.
    https://doi.org/10.3390/ijms23158489
    AMA Style
    
                                Xu L,                                 Shao F,                                 Luo T,                                 Li Q,                                 Tan D,                                 Tan Y.        
                Pan-Cancer Analysis Identifies CHD5 as a Potential Biomarker for Glioma. International Journal of Molecular Sciences. 2022; 23(15):8489.
        https://doi.org/10.3390/ijms23158489
    
    Chicago/Turabian Style
    
                                Xu, Lei,                                 Fengling Shao,                                 Tengling Luo,                                 Qijun Li,                                 Dongmei Tan,                                 and Yi Tan.        
                2022. "Pan-Cancer Analysis Identifies CHD5 as a Potential Biomarker for Glioma" International Journal of Molecular Sciences 23, no. 15: 8489.
        https://doi.org/10.3390/ijms23158489
    
    APA Style
    
                                Xu, L.,                                 Shao, F.,                                 Luo, T.,                                 Li, Q.,                                 Tan, D.,                                 & Tan, Y.        
        
        (2022). Pan-Cancer Analysis Identifies CHD5 as a Potential Biomarker for Glioma. International Journal of Molecular Sciences, 23(15), 8489.
        https://doi.org/10.3390/ijms23158489